Skip to main content
In stock | Immunotherapy (Monoclonal Antibody)

Isatuximab

Oncology Type Hematologic (Multiple Myeloma)
Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
No Image
Description

Isatuximab is classified as an Anti-CD38 / SLAMF7 mAb, sourced for use within our Immunotherapy (Monoclonal Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Immunotherapy (Monoclonal Antibody)
Oncology Type Hematologic (Multiple Myeloma)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3